From major journals, first or last author from the Institute for Cancer Research
Wang T, Gautam P, Rousu J, Aittokallio T(2020) Systematic mapping of cancer cell target dependencies using high-throughput drug screening in triple-negative breast cancer Comput Struct Biotechnol J, 18, 3819-3832 DOI 10.1016/j.csbj.2020.11.001, PubMed 33335681
Berg KCG, Brunsell TH, Sveen A, Alagaratnam S, Bjørnslett M, Hektoen M, Brudvik KW, Røsok BI, Bjørnbeth BA, Nesbakken A, Lothe RA(2020) Genomic and prognostic heterogeneity among RAS/BRAFV600E /TP53 co-mutated resectable colorectal liver metastases Mol Oncol(in press) DOI 10.1002/1878-0261.12885, PubMed 33325154
Lachota M, Vincenti M, Winiarska M, Boye K, Zagożdżon R, Malmberg KJ(2020) Prospects for NK Cell Therapy of Sarcoma Cancers (Basel), 12(12) DOI 10.3390/cancers12123719, PubMed 33322371
Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, Pooley KA, Parsons MT, Fortuno C, Wang Q, Bolla MK, Dennis J, Keeman R, Alonso MR, Álvarez N, Herraez B, Fernandez V, Núñez-Torres R, Osorio A, Valcich J, Li M, Törngren T, Harrington PA, Baynes Cet al.(2021) Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women N Engl J Med(in press) DOI 10.1056/NEJMoa1913948, PubMed 33471991
Galili B, Tekpli X, Kristensen VN, Yakhini Z(2021) Efficient gene expression signature for a breast cancer immuno-subtype PLoS One, 16(1), e0245215 DOI 10.1371/journal.pone.0245215, PubMed 33434192
Stjepanovic N, Lubinski J, Moller P, Randall Armel S, Foulkes WD, Tung N, Neuhausen SL, Kotsopoulos J, Sun P, Sun S, Eisen A, Narod SA, Hereditary Breast Cancer Clinical Study Group(2021) Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers Breast Cancer Res Treat(in press) DOI 10.1016/j.ejca.2020.03.009, PubMed 33423179